Targeted Correction and Restored Function of the CFTR Gene in Cystic Fibrosis Induced Pluripotent Stem Cells

Recently developed reprogramming and genome editing technologies make possible the derivation of corrected patient-specific pluripotent stem cell sources—potentially useful for the development of new therapeutic approaches. Starting with skin fibroblasts from patients diagnosed with cystic fibrosis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Crane, Ana M., Kramer, Philipp, Bui, Jacquelin H., Chung, Wook Joon, Li, Xuan Shirley, Gonzalez-Garay, Manuel L., Hawkins, Finn, Liao, Wei, Mora, Daniela, Choi, Sangbum, Wang, Jianbin, Sun, Helena C., Paschon, David E., Guschin, Dmitry Y., Gregory, Philip D., Kotton, Darrell N., Holmes, Michael C., Sorscher, Eric J., Davis, Brian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400651/
https://www.ncbi.nlm.nih.gov/pubmed/25772471
http://dx.doi.org/10.1016/j.stemcr.2015.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400651/
https://www.ncbi.nlm.nih.gov/pubmed/25772471
http://dx.doi.org/10.1016/j.stemcr.2015.02.005

Ejemplares similares